مصطفى سولاك ، دكتوراه في الطب ، هو طبيب تخرج من كلية الطب بجامعة هاسيتيب وأتم إقاماته في مستشفى شيشلي إتفال التعليمي والبحوث بإسطنبول ومنح الزمالة في معهد السرطان بجامعة هاسيتيب. وهو متخصص في سرطان الثدي وسرطان الخصية وسرطان المبيض وسرطان الرئة وسرطان الرأس والعنق وسرطان الجهاز الهضمي. وقد عمل أيضًا في مركز إم دي أندرسون للسرطان بجامعة تكساس ، ومستشفى كوروم للتدريب بجامعة هيتيت ، ومستشفى ميديكال بارك.
اقرأ المزيدمصطفى سولاك ، دكتوراه في الطب ، هو طبيب تخرج من كلية الطب بجامعة هاسيتيب وأتم إقاماته في مستشفى شيشلي إتفال التعليمي والبحوث بإسطنبول ومنح الزمالة في معهد السرطان بجامعة هاسيتيب. وهو متخصص في سرطان الثدي وسرطان الخصية وسرطان المبيض وسرطان الرئة وسرطان الرأس والعنق وسرطان الجهاز الهضمي. وقد عمل أيضًا في مركز إم دي أندرسون للسرطان بجامعة تكساس ، ومستشفى كوروم للتدريب بجامعة هيتيت ، ومستشفى ميديكال بارك.
| تكلفة استشارة الطبيب | السعر عند الطلب |
| الترددات اللاسلكية | $10000 - $18000 |
| زرع نخاع العظم | $19900 - $30000 |
| العلاج المناعي مع Keytruda (Pembolizumab) | $5800 - $6000 |
تخرج الدكتور طارق أكار من كلية جراح باشا للطب بجامعة اسطنبول عام 2000 وحصل على لقب "طبيب باطني" في عام 2004. وقد نشر 19 بحثًا دوليًا و 6 أوراق محلية و 25 عرضًا تقديميًا في المؤتمرات المحلية والدولية. تشمل مجالات اهتماماته الطبية Achalasia و ESD و ERCP و Zenker Diverticulum و Gastroparesis.
اقرأ المزيدتخرج الدكتور طارق أكار من كلية جراح باشا للطب بجامعة اسطنبول عام 2000 وحصل على لقب "طبيب باطني" في عام 2004. وقد نشر 19 بحثًا دوليًا و 6 أوراق محلية و 25 عرضًا تقديميًا في المؤتمرات المحلية والدولية. تشمل مجالات اهتماماته الطبية Achalasia و ESD و ERCP و Zenker Diverticulum و Gastroparesis.
| تكلفة استشارة الطبيب | السعر عند الطلب |
| الترددات اللاسلكية | $10000 - $18000 |
| زرع نخاع العظم | $19900 - $30000 |
| العلاج المناعي مع Keytruda (Pembolizumab) | $5800 - $6000 |
Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.
Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."
In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.
اقرأ المزيدDr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.
Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."
In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.
Eğitim:
Uzmanlık Eğitimi ve Deneyim:
Akademik Kariyer:
Eğitim:
Uzmanlık Eğitimi ve Deneyim:
Akademik Kariyer:
2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career
Medicine Department of Internal Medicine
2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital
2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology
2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital
2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology
Memberships in Scientific Organizations
ASCO
ESMO
TTOD
AVOD
Publications
In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.
Awards Received
EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award
"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"
Speeches Delivered at National Congresses, Conferences, and Symposia:
Courses, Meetings, and Certificates
ESMO certified Medical Oncologist since 2019
اقرأ المزيد
2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career
Medicine Department of Internal Medicine
2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital
2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology
2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital
2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology
Memberships in Scientific Organizations
ASCO
ESMO
TTOD
AVOD
Publications
In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.
Awards Received
EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award
"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"
Speeches Delivered at National Congresses, Conferences, and Symposia:
Courses, Meetings, and Certificates
ESMO certified Medical Oncologist since 2019
Born in Trabzon in 1972, Dr. İzzettin Kahraman began his medical studies at Karadeniz Technical University Faculty of Medicine in 1989 and earned his Medical Doctor degree in 1995. Following two years as a general practitioner, he embarked on his specialization training in 1997. He completed his residency at Ankara Oncology Training and Research Hospital, becoming a General Surgery Specialist in 2002.
Dr. Kahraman worked as a General Surgery Specialist in public hospitals, including Trabzon Numune Hospital and Bakırköy Dr. Sadi Konuk Training and Research Hospital, for 13 years. From 2016 to 2018, he served as a Lecturer at University of Health Sciences. In 2019, he transitioned to the private sector, continuing his career in private hospitals.
Throughout his career, Dr. Kahraman has engaged in a wide range of training programs both in Turkey and abroad. In 2007, he earned a Surgical Endoscopy Certificate and furthered his expertise in laparoscopic hernia treatments in Hamburg, Germany, in 2008. He also completed a course on Nutrition Practices and Training at Ondokuz Mayis University and a specialized course in laparoscopic hernia repair in Istanbul in 2010.
In 2011, after completing the "Emergency Surgery" course in Istanbul organized by the European Society for Trauma and Emergency Surgery (ESTES), Dr. Kahraman received training in SILS (Single Incision Laparoscopic Surgery) Cholecystectomy at Gazi University in Ankara. Since then, he has specialized in advanced laparoscopic techniques, with a particular focus on endoscopy, gastric diseases, obesity, and metabolic surgery.
In 2021, Dr. Kahraman obtained certificates in Ozone Therapy and Mesotherapy from Medipol University.
Since 2023, he has been serving at Estexper Clinic, Istanbul.
اقرأ المزيدBorn in Trabzon in 1972, Dr. İzzettin Kahraman began his medical studies at Karadeniz Technical University Faculty of Medicine in 1989 and earned his Medical Doctor degree in 1995. Following two years as a general practitioner, he embarked on his specialization training in 1997. He completed his residency at Ankara Oncology Training and Research Hospital, becoming a General Surgery Specialist in 2002.
Dr. Kahraman worked as a General Surgery Specialist in public hospitals, including Trabzon Numune Hospital and Bakırköy Dr. Sadi Konuk Training and Research Hospital, for 13 years. From 2016 to 2018, he served as a Lecturer at University of Health Sciences. In 2019, he transitioned to the private sector, continuing his career in private hospitals.
Throughout his career, Dr. Kahraman has engaged in a wide range of training programs both in Turkey and abroad. In 2007, he earned a Surgical Endoscopy Certificate and furthered his expertise in laparoscopic hernia treatments in Hamburg, Germany, in 2008. He also completed a course on Nutrition Practices and Training at Ondokuz Mayis University and a specialized course in laparoscopic hernia repair in Istanbul in 2010.
In 2011, after completing the "Emergency Surgery" course in Istanbul organized by the European Society for Trauma and Emergency Surgery (ESTES), Dr. Kahraman received training in SILS (Single Incision Laparoscopic Surgery) Cholecystectomy at Gazi University in Ankara. Since then, he has specialized in advanced laparoscopic techniques, with a particular focus on endoscopy, gastric diseases, obesity, and metabolic surgery.
In 2021, Dr. Kahraman obtained certificates in Ozone Therapy and Mesotherapy from Medipol University.
Since 2023, he has been serving at Estexper Clinic, Istanbul.
Dr. Bilal Ergul, MD, is a pioneering force in the field of gastroenterology.
His innovative treatment protocols have transformed the lives of many patients, including a remarkable case where he successfully treated a patient with a Peroral Endoscopic Myotomy (POEM) surgery.
Dr. Bilal Ergul, often says, ‘Healing is more than treating a condition; it’s about restoring hope and improving lives.’ This philosophy is evident in every aspect of his work, making his and his team truly inspirational figure in the medical community."
He has authored around 100 publications in different academic topics
Dr. Bilal Ergul, MD, is a pioneering force in the field of gastroenterology.
His innovative treatment protocols have transformed the lives of many patients, including a remarkable case where he successfully treated a patient with a Peroral Endoscopic Myotomy (POEM) surgery.
Dr. Bilal Ergul, often says, ‘Healing is more than treating a condition; it’s about restoring hope and improving lives.’ This philosophy is evident in every aspect of his work, making his and his team truly inspirational figure in the medical community."
He has authored around 100 publications in different academic topics
Experience:
2022 -
Medipol Bahçelievler
2021 - 2022
MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL
2018 - 2020
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
2014 - 2020
TOKAT STATE HOSPITAL
2010 - 2010
BINGOL STATE HOSPITAL
Education:
2021
MEDIPOL UNIVERSITY, GASTROTEROLOGY
2018
İSTINYE UNIVERSITY, INTERNAL DISEASES USA
2014
ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY
2010
FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT
2004
FIRAT UNIVERSITY, FACULTY OF MEDICINE
A. International Peer-Reviewed Journal Articles:
Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.
Title: Acute gastric obstruction resulting from gallstone-induced bezoar.
Title: Garlic-induced esophagitis.
Title: Association between Helicobacter pylori and liver-to-spleen ratio.
Title: Crohn's disease masked by median arcuate ligament syndrome.
Title: Telaprevir and anemia: What we learned from the first three patients.
Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.
Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?
Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.
Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."
Title: Severe acute pancreatitis due to hypertriglyceridemia.
Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.
Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.
Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.
Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.
Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.
B. Contributions to Scientific Conferences:
Title: Suicidal poisonings in Turkey: demographic and clinical aspects.
Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.
Experience:
2022 -
Medipol Bahçelievler
2021 - 2022
MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL
2018 - 2020
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
2014 - 2020
TOKAT STATE HOSPITAL
2010 - 2010
BINGOL STATE HOSPITAL
Education:
2021
MEDIPOL UNIVERSITY, GASTROTEROLOGY
2018
İSTINYE UNIVERSITY, INTERNAL DISEASES USA
2014
ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY
2010
FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT
2004
FIRAT UNIVERSITY, FACULTY OF MEDICINE
A. International Peer-Reviewed Journal Articles:
Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.
Title: Acute gastric obstruction resulting from gallstone-induced bezoar.
Title: Garlic-induced esophagitis.
Title: Association between Helicobacter pylori and liver-to-spleen ratio.
Title: Crohn's disease masked by median arcuate ligament syndrome.
Title: Telaprevir and anemia: What we learned from the first three patients.
Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.
Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?
Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.
Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."
Title: Severe acute pancreatitis due to hypertriglyceridemia.
Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.
Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.
Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.
Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.
Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.
B. Contributions to Scientific Conferences:
Title: Suicidal poisonings in Turkey: demographic and clinical aspects.
Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.
| تكلفة استشارة الطبيب | السعر عند الطلب |
| استئصال ورم عبر الأنف | $10000 - $15000 |
| استئصال البروستاتا بالمنظار | $6000 |
| استئصال قطعة الرئة | $12000 - $15000 |
| تكلفة استشارة الطبيب | السعر عند الطلب |
| الترددات اللاسلكية | $10000 - $18000 |
| زرع نخاع العظم | $19900 - $30000 |
| العلاج المناعي مع Keytruda (Pembolizumab) | $5800 - $6000 |
Education
MD; Hacettepe University Faculty of Medicine (2001)
Residencies
Internal Medicine; Ministry of Health Ankara Diskapi Education and Research Hospital (2009)
Pathology; Gazi University Faculty of Medicine (2004)
Fellowships
Gastroenterology and Hepatology; Necmettin Erbakan University Faculty of Medicine (2013)
Experiences
Demiroglu Bilim University Faculty of Medicine, Department of Gastroenterology and Hepatology
Istanbul Florence Nightingale Hospital (2019- currently)
Alanya Alaaddin Keykubat University Faculty of Medicine, Department of Gastroenterology and Hepatology (2017-2019)
Bundang CHA Hospital, Seoul, Korea (2018)
Konya Education and Research Hospital, Department of Gastroenterology (2014-2017)
Certificates
Advanced Endoscopy Certificate, Bundang CHA Hospital, Seoul, Korea, 2018
Bariatric Endoscopy Certificate, Bariatric Endoscopy Global course, Sao Paulo, Brazil, 2020
Awards
2019 Rising Star, 10th Digestive Disease and Endoscopy Symposium
Memberships
Turkish Society of Internal Medicine
Turkish Society of Gastroenterology
ERCP Study Group at Turkish Society of Gastroenterology
European Society of Gastrointestinal Endoscopy
Women in Endoscopy, American Society of Gastrointestinal Endoscopy
اقرأ المزيدEducation
MD; Hacettepe University Faculty of Medicine (2001)
Residencies
Internal Medicine; Ministry of Health Ankara Diskapi Education and Research Hospital (2009)
Pathology; Gazi University Faculty of Medicine (2004)
Fellowships
Gastroenterology and Hepatology; Necmettin Erbakan University Faculty of Medicine (2013)
Experiences
Demiroglu Bilim University Faculty of Medicine, Department of Gastroenterology and Hepatology
Istanbul Florence Nightingale Hospital (2019- currently)
Alanya Alaaddin Keykubat University Faculty of Medicine, Department of Gastroenterology and Hepatology (2017-2019)
Bundang CHA Hospital, Seoul, Korea (2018)
Konya Education and Research Hospital, Department of Gastroenterology (2014-2017)
Certificates
Advanced Endoscopy Certificate, Bundang CHA Hospital, Seoul, Korea, 2018
Bariatric Endoscopy Certificate, Bariatric Endoscopy Global course, Sao Paulo, Brazil, 2020
Awards
2019 Rising Star, 10th Digestive Disease and Endoscopy Symposium
Memberships
Turkish Society of Internal Medicine
Turkish Society of Gastroenterology
ERCP Study Group at Turkish Society of Gastroenterology
European Society of Gastrointestinal Endoscopy
Women in Endoscopy, American Society of Gastrointestinal Endoscopy
Education:
Akdeniz University Faculty of Medicine
Specialization Training:
Baskent University Faculty of Medicine. Internal diseases
Akdeniz University Faculty of Medicine, Gastroenterology Minor
Worked Institutions:
Tekirdag State Hospital (Compulsory Service)
Demiroğlu Bilim University Faculty of Medicine, Gastroenterology
Medical Interests:
Endoscopy-Colonoscopy
ERCP
Hepatology
Inflammatory Bowel Diseases
Liver Transplantation
اقرأ المزيدEducation:
Akdeniz University Faculty of Medicine
Specialization Training:
Baskent University Faculty of Medicine. Internal diseases
Akdeniz University Faculty of Medicine, Gastroenterology Minor
Worked Institutions:
Tekirdag State Hospital (Compulsory Service)
Demiroğlu Bilim University Faculty of Medicine, Gastroenterology
Medical Interests:
Endoscopy-Colonoscopy
ERCP
Hepatology
Inflammatory Bowel Diseases
Liver Transplantation
ACADEMIC CAREER SUMMARY
Degree: Bachelor's
Field: Medicine
University: Atatürk University
Year: 2001
Degree: Master's
Field: Medicine
University: Atatürk University
Year: 2001
Specialization/Doctorate: Internal Medicine/Gastroenterology
University: İnönü University
Year: 2012
Associate Professorship: Gastroenterology
University: İnönü University
Year: 2018
Foreign Language: English, 67.5, 2007
H-index (WoS/Google): 8/10
Impact Factor: 8.1577
Key Research Work:
“Does apocynin increase liver regeneration in the partial hepatectomy model?” Yılmaz Bilgiç, Burhan Hakan Kanat, Onural ÖZHAN, Azibe YILDIZ, Zeynep AKSUNGUR, Mehmet Erman ERDEMLİ, Nigar VARDI, Yusuf TÜRKÖZ, Sami AKBULUT, Adem KÖSE, Hakan PARLAKPINAR. Turkish Journal of Medical Sciences, 2023 (53), 1-12 Q3.
Declared Project Title, Year:
K.3.6. “Investigation of the Effects of Vinpocetine in Sepsis Created by Cecal Ligation and Puncture in Rats” (Principal Investigator), 2023
International Experience:
Advanced Endoscopy Training, Anam Hospital, South Korea (3 months, 2016)
Advanced ERCP Course, Olympus Training Center, Hamburg (2017)
ADMINISTRATIVE POSITIONS
ACADEMIC CAREER SUMMARY
Degree: Bachelor's
Field: Medicine
University: Atatürk University
Year: 2001
Degree: Master's
Field: Medicine
University: Atatürk University
Year: 2001
Specialization/Doctorate: Internal Medicine/Gastroenterology
University: İnönü University
Year: 2012
Associate Professorship: Gastroenterology
University: İnönü University
Year: 2018
Foreign Language: English, 67.5, 2007
H-index (WoS/Google): 8/10
Impact Factor: 8.1577
Key Research Work:
“Does apocynin increase liver regeneration in the partial hepatectomy model?” Yılmaz Bilgiç, Burhan Hakan Kanat, Onural ÖZHAN, Azibe YILDIZ, Zeynep AKSUNGUR, Mehmet Erman ERDEMLİ, Nigar VARDI, Yusuf TÜRKÖZ, Sami AKBULUT, Adem KÖSE, Hakan PARLAKPINAR. Turkish Journal of Medical Sciences, 2023 (53), 1-12 Q3.
Declared Project Title, Year:
K.3.6. “Investigation of the Effects of Vinpocetine in Sepsis Created by Cecal Ligation and Puncture in Rats” (Principal Investigator), 2023
International Experience:
Advanced Endoscopy Training, Anam Hospital, South Korea (3 months, 2016)
Advanced ERCP Course, Olympus Training Center, Hamburg (2017)
ADMINISTRATIVE POSITIONS
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
اقرأ المزيد
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
| تكلفة استشارة الطبيب | السعر عند الطلب |
| استئصال ورم عبر الأنف | $10000 - $15000 |
| استئصال البروستاتا بالمنظار | $6000 |
| استئصال قطعة الرئة | $12000 - $15000 |
Gastroenterology
Pendik Medipol University Hospital
1999 Karadeniz Technical University, Gastroenterology
1997Atatürk University, Internal Diseases Professorship
1992 Atatürk University, Internal Diseases Associated Professorship
1985 Atatürk University, Internal Diseases Specialist
1981 Atatürk University Faculty of Medicine
1- Nihat Okçu Gülçin Polat,Arif Yılmaz,Mehmet Koruk,The demographıc features of gastrıc cancers ın erzurum(Eurasian J Med 2000; 32: 63-65)
2- Üst Gastrointestinal Kanamalı Olguların Bir Değerlendirilmesi. Klinik Bilimler-Doktor.2000, - E.akarsu,N.Okçu, ve Ark.Kuzeydoğu Anadolu’da 6:4:435-438
3-N.Okçu, A.yılmaz. İ.kiki,M.D.onuk, C.gündoğdu, H.uzunismail. Tanısal Üst Gastrointestinal endoskopi Sonuçlarımız. Atatürk Üniversitesi Tıp Dergisi 1997,29 (2):486
4-N. Okçu, M.gündoğdu, M.D. onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, i. çapoğlu. Nonsteroid Anti İnflamatuar İlaç (NSAİİ) Kullanan Hastalarda oluşan Gastroduodenal Lezyonların Önlenmesinde Misoprostolün Yeri. Atatürk Üniversitesi Tıp Dergisi 1997,29 (2):453-455.
5-N.Okçu, A. öz, m.d. onuk, e.akarsu, b. tekin, h.z. tonbul, h.kaya. Kronik Aktif Hepatit İle Dekopanse Karaciğer Parankim Yetmezliğinde Plazma Fibronektin Düzeyleri ve Karaciğerin Fonksiyon Durumu İle İlişkisi. Türk J. Gastroenterol 1995;27(4): 422-426.
6-N.Okçu, tahir buran,m.d. onuk,a. yılmaz, e.akarsu, g. akçay. Erzurum ve Çevresinde Duodenum Ülserli Hastalarda Helicobacter Pylori Prevelansı. Türk J. Gastroenterol 1995;27(4): 447-450.
7-N.Okçu, b.s. uyanık, e. akarsu, e. bakan, z. tonbul. Mide ve Kolorektal Kanserlerinde Karbonhidrat Antijenleri (CA-19-9, CA-125), Karsinoembriyonik Antijen (CEA) ve Alkalen Fosfatazın Önemi. Türk J. Gastroenterol 1995;6:467-471.
8-N. Okçu, m.d. onuk, e. akarsu, h. doğan, c. gündoğdu. Bölgemizdeki Hepatoselüler Karsinomlu Hastalarda Major Risk Faktörleri. Gastroenteroloji 1994;5(2):154-157
9-N.Okçu, m.d. onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Erzurum Bölgesinde Gastrik Karsinom Sıklığı, Endoskopik ce Histolojik Özellikler. Gastroenteroloji 1994;5(2):263-267.
10-N. Okçu, m.d. onuk, tahir buran, e. akarsu, m.a. çiftçioğlu. Erzurum İli Çevresinde Nonspesifik Gastritli Olgularda Helicobacter Pylori Sıklığı. Gastroenteroloji 1994;5(2):211-213.
11-N.Okçu, m.d. onuk, ö. ünal, e. akarsu, l. incesu, k. akgöz. Karın İçi Kitle Lezyonlarında Ultrason Rehberliğinde Yapılan İnce İğne Aspirasyon Biyopsisinin Tanı Değeri. Gastroenteroloji 1993;4(1):166-68.
12-N.O.kçu, m.d. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Sendromu (2 Olgu). Türk J Gastroenterhepatol 1993; 4(1):77-80.
13-N.Okçu, h. koçak, m.d. onuk, m. gündoğdu, e. bakan, a. yılmaz, a. başoğlu, a. ateş, f.a. paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriüretic Peptide (ANP) Levels. Vascular Surgery 1993; 27(2): 128-132
15-N.Okçu, m.d. onuk, a.yılmaz, m. gündoğdu, t. buran. Omeprozol ve Ranitidinin Peptik Ülser İyileşmesine Etkileri. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.
16-N. Okçu, m.r. yiğitoğlu, b. adam, e. bakan. Konjestif Kalp Yetersizliği Olan Hastalarda Digıxin’in Plazma Atrial Natriüretik Peptik Düzeyine Etkisi. S.Ü. Tıp Fak. Dergisi 1991;7(2):243-247..
17-N.Okçu, a. yılmaz. Üst Gastrointestinal Sistem Kanamalarında Histamin H2 -Reseptör Antagonistlerinin Etkisi. Endoskopi Dergisi 1991;2(4):17-23.
18-N.Okçu, E. bakan, b. adam, a. yılmaz, m.r. yiğitoğlu. Kronik Hepatit ve Karaciğer Sirozlu Hastalarda Seks Hormanları ve Seks Hormon Bağlayıcı Globülin Seviyeleri (Editöre Mektup). Doğa-Tr. J. Of Medical Sciences 1991;15:1-2.
19-N.Okcu Ömer Yılmaz.Helıcobacter pylorı and related gastroıntestınal system dıseases Turkiye Klinikleri JMed Sci. 2013;33(3):806-13
20-Nihat Okçu , Ömer yılmaz, hakan dursun, gülçin polat. Dispeptik semptomlarla beslenme alışkanlıkları, endoskopik ve histolojik bulgular arasındaki ilişki (Eurasian J Med 2006; 38: 13-17)
21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayır,1Ibrahim Pirim,2Salim B. Tekin,1andCemal Gundogdu3 - Distribuion of HLA Tissue Groups in Patients with Gastric Cancer Eurasian J Med. 2010 Apr; 42(1): 9.11.
22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu :The fibroblast proliferation,relationship of hepatocyte growth factor (HGF) and interferon-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404
23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sarı,Nihat Okcu,Abdulhalim Baki. The effect of fish oil on stress ulcer prophylaxis GastroenterologyVolume 118, Issue 4, Part 2, PageA1255
اقرأ المزيدGastroenterology
Pendik Medipol University Hospital
1999 Karadeniz Technical University, Gastroenterology
1997Atatürk University, Internal Diseases Professorship
1992 Atatürk University, Internal Diseases Associated Professorship
1985 Atatürk University, Internal Diseases Specialist
1981 Atatürk University Faculty of Medicine
1- Nihat Okçu Gülçin Polat,Arif Yılmaz,Mehmet Koruk,The demographıc features of gastrıc cancers ın erzurum(Eurasian J Med 2000; 32: 63-65)
2- Üst Gastrointestinal Kanamalı Olguların Bir Değerlendirilmesi. Klinik Bilimler-Doktor.2000, - E.akarsu,N.Okçu, ve Ark.Kuzeydoğu Anadolu’da 6:4:435-438
3-N.Okçu, A.yılmaz. İ.kiki,M.D.onuk, C.gündoğdu, H.uzunismail. Tanısal Üst Gastrointestinal endoskopi Sonuçlarımız. Atatürk Üniversitesi Tıp Dergisi 1997,29 (2):486
4-N. Okçu, M.gündoğdu, M.D. onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, i. çapoğlu. Nonsteroid Anti İnflamatuar İlaç (NSAİİ) Kullanan Hastalarda oluşan Gastroduodenal Lezyonların Önlenmesinde Misoprostolün Yeri. Atatürk Üniversitesi Tıp Dergisi 1997,29 (2):453-455.
5-N.Okçu, A. öz, m.d. onuk, e.akarsu, b. tekin, h.z. tonbul, h.kaya. Kronik Aktif Hepatit İle Dekopanse Karaciğer Parankim Yetmezliğinde Plazma Fibronektin Düzeyleri ve Karaciğerin Fonksiyon Durumu İle İlişkisi. Türk J. Gastroenterol 1995;27(4): 422-426.
6-N.Okçu, tahir buran,m.d. onuk,a. yılmaz, e.akarsu, g. akçay. Erzurum ve Çevresinde Duodenum Ülserli Hastalarda Helicobacter Pylori Prevelansı. Türk J. Gastroenterol 1995;27(4): 447-450.
7-N.Okçu, b.s. uyanık, e. akarsu, e. bakan, z. tonbul. Mide ve Kolorektal Kanserlerinde Karbonhidrat Antijenleri (CA-19-9, CA-125), Karsinoembriyonik Antijen (CEA) ve Alkalen Fosfatazın Önemi. Türk J. Gastroenterol 1995;6:467-471.
8-N. Okçu, m.d. onuk, e. akarsu, h. doğan, c. gündoğdu. Bölgemizdeki Hepatoselüler Karsinomlu Hastalarda Major Risk Faktörleri. Gastroenteroloji 1994;5(2):154-157
9-N.Okçu, m.d. onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Erzurum Bölgesinde Gastrik Karsinom Sıklığı, Endoskopik ce Histolojik Özellikler. Gastroenteroloji 1994;5(2):263-267.
10-N. Okçu, m.d. onuk, tahir buran, e. akarsu, m.a. çiftçioğlu. Erzurum İli Çevresinde Nonspesifik Gastritli Olgularda Helicobacter Pylori Sıklığı. Gastroenteroloji 1994;5(2):211-213.
11-N.Okçu, m.d. onuk, ö. ünal, e. akarsu, l. incesu, k. akgöz. Karın İçi Kitle Lezyonlarında Ultrason Rehberliğinde Yapılan İnce İğne Aspirasyon Biyopsisinin Tanı Değeri. Gastroenteroloji 1993;4(1):166-68.
12-N.O.kçu, m.d. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Sendromu (2 Olgu). Türk J Gastroenterhepatol 1993; 4(1):77-80.
13-N.Okçu, h. koçak, m.d. onuk, m. gündoğdu, e. bakan, a. yılmaz, a. başoğlu, a. ateş, f.a. paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriüretic Peptide (ANP) Levels. Vascular Surgery 1993; 27(2): 128-132
15-N.Okçu, m.d. onuk, a.yılmaz, m. gündoğdu, t. buran. Omeprozol ve Ranitidinin Peptik Ülser İyileşmesine Etkileri. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.
16-N. Okçu, m.r. yiğitoğlu, b. adam, e. bakan. Konjestif Kalp Yetersizliği Olan Hastalarda Digıxin’in Plazma Atrial Natriüretik Peptik Düzeyine Etkisi. S.Ü. Tıp Fak. Dergisi 1991;7(2):243-247..
17-N.Okçu, a. yılmaz. Üst Gastrointestinal Sistem Kanamalarında Histamin H2 -Reseptör Antagonistlerinin Etkisi. Endoskopi Dergisi 1991;2(4):17-23.
18-N.Okçu, E. bakan, b. adam, a. yılmaz, m.r. yiğitoğlu. Kronik Hepatit ve Karaciğer Sirozlu Hastalarda Seks Hormanları ve Seks Hormon Bağlayıcı Globülin Seviyeleri (Editöre Mektup). Doğa-Tr. J. Of Medical Sciences 1991;15:1-2.
19-N.Okcu Ömer Yılmaz.Helıcobacter pylorı and related gastroıntestınal system dıseases Turkiye Klinikleri JMed Sci. 2013;33(3):806-13
20-Nihat Okçu , Ömer yılmaz, hakan dursun, gülçin polat. Dispeptik semptomlarla beslenme alışkanlıkları, endoskopik ve histolojik bulgular arasındaki ilişki (Eurasian J Med 2006; 38: 13-17)
21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayır,1Ibrahim Pirim,2Salim B. Tekin,1andCemal Gundogdu3 - Distribuion of HLA Tissue Groups in Patients with Gastric Cancer Eurasian J Med. 2010 Apr; 42(1): 9.11.
22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu :The fibroblast proliferation,relationship of hepatocyte growth factor (HGF) and interferon-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404
23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sarı,Nihat Okcu,Abdulhalim Baki. The effect of fish oil on stress ulcer prophylaxis GastroenterologyVolume 118, Issue 4, Part 2, PageA1255
مرخص أخصائي علاج الأورام بالإشعاع مع 8 سنوات من التدريب الطبي ، بما في ذلك الدراسات الجامعية في كلية الطب بجامعة مرمرة (2004-2011) والتدريب المتخصص في علاج الأورام بالإشعاع في كلية الطب بجامعة مرمرة (2012-2016). التعليم السابق من مدرسة Sixteen Numbered Shirvan School (أذربيجان) الثانوية (1998-2004).
اقرأ المزيدمرخص أخصائي علاج الأورام بالإشعاع مع 8 سنوات من التدريب الطبي ، بما في ذلك الدراسات الجامعية في كلية الطب بجامعة مرمرة (2004-2011) والتدريب المتخصص في علاج الأورام بالإشعاع في كلية الطب بجامعة مرمرة (2012-2016). التعليم السابق من مدرسة Sixteen Numbered Shirvan School (أذربيجان) الثانوية (1998-2004).
| تكلفة استشارة الطبيب | السعر عند الطلب |
| العلاج الكيميائي داخل الصفاق مفرط الحرارة (HIPEC) | $28000 - $47000 |
| استئصال قطعة الرئة | $12000 - $20000 |
| جراحة ورم الغدة النخامية | $6800 |